Related Experiment Video
Updated: Nov 20, 2025

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
[Information and misinformation about adverse drug reactions]
Niels August Willer Strand1, Siri Vinther, Henrik Horwitz
1niels.august.willer.strand@regionh.dk.
Abstract:
In this review, we critically discuss the information distributed to patients and doctors regarding adverse drug reactions. A major concern is that frequencies reported in the summary of product characteristics are not adjusted for the occurrence of side effects observed in the placebo group. Previous research has found that the understanding of the health hazards related to pharmacotherapy can be significantly improved by providing information on the frequencies of adverse drug reactions in both the active- and the placebo group.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Allergic Drug Reactions
Drug Regulation
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...

